Cowen And Company, LLC Editas Medicine, Inc. Call Options Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$26.55 - $40.57 $923,940 - $1.41 Million
-34,800 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$39.27 - $72.94 $1.37 Million - $2.54 Million
34,800 New
34,800 $2,000
Q2 2021

Aug 13, 2021
SELL
$31.29 - $56.64 $757,218 - $1.37 Million
-24,200 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$39.71 - $90.58 $960,982 - $2.19 Million
24,200 New
24,200 $7,000

Others Institutions Holding EDIT

# of Institutions
250
Shares Held
57.1M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $83.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email